VALBIOTIS SA: Valbiotis opens a new growth driver with the launch of its full product range on Amazon France

What happened

Valbiotis, a French laboratory focused on cardiometabolic health, announced that its full ValbiotisPRO and ValbiotisPLUS product ranges will be listed on Amazon France from October 26, 2026, with sales and first deliveries starting mid-November 2026.

Confirmed

Global impact / market context

Selling on Amazon adds a direct online route to buyers alongside pharmacies, which could widen the customer base and lift product revenue. It also brings new costs for advertising and platform fees, so profit per sale may differ from pharmacy sales.

Analyst inference

The company frames digital as a growing driver of the food supplement market, and the release describes Amazon as a channel that complements pharmacies rather than replacing them. That suggests online marketplaces are becoming an added distribution layer for smaller health-product makers.

Analyst inference

What to watch

1. Valbiotis said products appear on Amazon France from October 26, 2026, but effective sales and first consumer deliveries begin mid-November 2026, allowing time to set up dedicated Amazon advertising campaigns. Confirmed
2. Watch whether Valbiotis discloses sales volumes, advertising spending, or platform fees from the Amazon channel, since these would show whether the new route adds revenue without eroding profit per sale. Proposed
3. Watch whether online sales pull customers away from pharmacy partners or add new buyers, because the company describes Amazon as complementary, and any channel conflict could affect relationships with pharmacies. Analyst inference

Evidence

• eqs-news.com